Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Nemorubicin

Base Information Edit
  • Chemical Name:Nemorubicin
  • CAS No.:108852-90-0
  • Molecular Formula:C32H37 N O13
  • Molecular Weight:643.64
  • Hs Code.:2933990090
  • European Community (EC) Number:808-225-3
  • UNII:7618O47BQM
  • DSSTox Substance ID:DTXSID6057619
  • Nikkaji Number:J488.795F
  • Wikidata:Q27120450
  • NCI Thesaurus Code:C83999
  • Metabolomics Workbench ID:56446
  • ChEMBL ID:CHEMBL1232279
  • Mol file:108852-90-0.mol
Nemorubicin

Synonyms:nemorubicin

Suppliers and Price of Nemorubicin
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • Nemorubicin
  • 1mg
  • $ 615.00
  • Crysdot
  • Nemorubicin 98+%
  • 5mg
  • $ 638.00
  • Crysdot
  • Nemorubicin 98+%
  • 10mg
  • $ 977.00
  • American Custom Chemicals Corporation
  • NEMORUBICIN 95.00%
  • 1MG
  • $ 930.30
Total 33 raw suppliers
Chemical Property of Nemorubicin Edit
Chemical Property:
  • Vapor Pressure:6.68E-31mmHg at 25°C 
  • Boiling Point:852.2°Cat760mmHg 
  • PKA:7.35±0.60(Predicted) 
  • Flash Point:469.2°C 
  • PSA:201.75000 
  • Density:1.55g/cm3 
  • LogP:0.28520 
  • XLogP3:1.7
  • Hydrogen Bond Donor Count:5
  • Hydrogen Bond Acceptor Count:14
  • Rotatable Bond Count:7
  • Exact Mass:643.22649023
  • Heavy Atom Count:46
  • Complexity:1160
Purity/Quality:

98%,99%, *data from raw suppliers

Nemorubicin *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOC(C6)OC)O
  • Isomeric SMILES:C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCO[C@@H](C6)OC)O
  • Recent EU Clinical Trials:Phase II randomized study of nemorubicin hydrochloride (PNU-152243A) or doxorubicin administered in adult patients with unresectable hepatocellular carcinoma
  • Uses Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives. It works primarily through topoisomerase I inhibition. Of note, Nemorubicin is active in cells with upregulation of the nucleotide excision repair (NER) pathway, where current therapies fail. Nemorubicin is biotransformed in the liver into cytotoxic metabolites that may further contribute to render this drug highly active against primary liver tumors or liver metastases.
Post RFQ for Price